SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Bloomberg
Stay informed with Bloomberg’s coverage and analysis for Fortune.
Page 54 of 100
Finance
Dollar and oil surge, stocks fall on Trump tariffs: markets wrap
By
Catherine Bosley
,
Matthew Burgess
, and others
Politics
Musk says DOGE is halting Treasury payments to US contractors
By
Gregory Korte
and
Bloomberg
Success
LinkedIn to tell job seekers how likely they are to get a response
By
Jo Constantz
and
Bloomberg
Finance
Trump tariffs target loophole used by Chinese online retailers
By
Jennifer A. Dlouhy
,
Josh Wingrove
, and others
Finance
JPMorgan plans $4 billion US gold delivery amid tariff fears
By
Jack Ryan
,
Jack Farchy
, and others
Politics
Downed Black Hawk was practicing secretive evacuation plans
By
Tony Capaccio
and
Bloomberg
Finance
‘Control of our destiny’: UPS braves blowback over Amazon break
By
Bloomberg
,
Cailley LaPara
, and others
Finance
Putin allows Goldman Sachs to sell its business in Russia
By
Bloomberg
,
Jenny Surane
, and others
Tech
Nvidia CEO Huang meets Trump at White House on Friday
By
Bloomberg
,
Stephanie Lai
, and others
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By
Bloomberg
and
Gerry Smith
Environment
DeepSeek and Ozempic are complicating decarbonization forecasts
By
Aaron Clark
and
Bloomberg
Finance
Europe’s banks kick off sweeping job cuts in ‘Year of Reckoning’
By
Harry Wilson
and
Bloomberg
Tech
Samsung’s chip division underwhelms in costly AI memory race
By
Yoolim Lee
and
Bloomberg
Finance
Swatch profit plunges almost 75%, hit by weakness in China
By
Paula Doenecke
and
Bloomberg
Health
Cigna plans to limit out-of-pocket drug costs for U.S. patients
By
Bloomberg
and
John Tozzi